UnitedHealth Group (NYSE:UNH) Stock Rating Reaffirmed by Jefferies Group

Rodiano Bonacci
Dicembre 10, 2017

The Amp Capital Investors Ltd holds 570,035 shares with $105.61 million value, up from 559,999 last quarter. The company has a market cap of $216,984.02, a P/E ratio of 23.32, a price-to-earnings-growth ratio of 1.66 and a beta of 0.66. The stock increased 1.69% or $2.26 during the last trading session, reaching $136.25. NG's SI was 12.84 million shares in December as released by FINRA. It is down 15.34% since December 9, 2016 and is downtrending. It has underperformed by 36.65% the S&P500.

Sigma Investment Counselors Inc decreased Unitedhealth Group Inc (UNH) stake by 9.29% reported in 2017Q2 SEC filing. Campbell Newman Asset Management Inc sold 24,331 shares as Unitedhealth Group (UNH)'s stock rose 9.50%. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate's stock valued at $113,000 after buying an additional 150 shares during the period. Decatur Mgmt Inc has invested 2.1% in UnitedHealth Group Incorporated (NYSE:UNH). The stock increased 1.71% or $3.76 during the last trading session, reaching $223.91. 2,233,073 shares of the stock were exchanged, compared to its average volume of 2,655,638. It has outperformed by 16.06% the S&P500. Da Davidson And reported 0.29% in UnitedHealth Group Incorporated (NYSE:UNH). It also upped Sarepta Therapeutics Inc (NASDAQ:SRPT) stake by 481,890 shares and now owns 2.03M shares. UNH's profit will be $2.42B for 22.39 P/E if the $2.50 EPS becomes a reality.

Investors of record on Friday, December 1st will be issued a dividend of $0.75 per share. Its up 0.04, from 0.98 in 2017Q1. It improved, as 53 investors sold UNH shares while 496 reduced holdings. Ltd. raised its stake in shares of UnitedHealth Group by 433.3% during the 2nd quarter. 816.36 million shares or 0.29% more from 813.97 million shares in 2017Q1 were reported.

Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. Oppenheimer Asset Mngmt stated it has 0.54% in UnitedHealth Group Incorporated (NYSE:UNH). Connecticut-based Bridgewater Assocs Lp has invested 0.01% in UnitedHealth Group Incorporated (NYSE:UNH). King Luther Cap Mngmt Corp has invested 0.02% in UnitedHealth Group Incorporated (NYSE:UNH). Renaissance Techs Lc invested in 0.01% or 185,200 shares. Crawford Inv Counsel holds 1,099 shares or 0.01% of its portfolio. Finally, BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $121,000. Letko Brosseau Assoc Incorporated reported 3,824 shares. Eaton Vance Mgmt holds 820,580 shares. UnitedHealth Group Incorporated has a 52-week low of $156.09 and a 52-week high of $231.77. Strategic Advsrs Ltd Liability reported 2,374 shares. South Dakota Invest Council accumulated 1.49% or 380,617 shares. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, September 26th. Therefore 48% are positive. During the same quarter in the prior year, the company earned $2.17 EPS. analysts predict that UnitedHealth Group will post 9.99 EPS for the current fiscal year. (NYSE:EAT). Landscape Mngmt Limited Liability Corporation owns 228,876 shares or 0.99% of their USA portfolio. In an analyst report revealed to clients and investors on Friday, 6 October, Mizuho Securities kept their "Buy" rating on shares of UNH. Cowen & Co has "Buy" rating and $57.0 target. Cleararc Cap has 0.81% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 27,080 shares. The stock has "Overweight" rating by Morgan Stanley on Wednesday, June 7. On Wednesday, August 16 the stock rating was maintained by Cantor Fitzgerald with "Buy". Jefferies maintained it with "Buy" rating and $215.0 target in Wednesday, August 16 report. The firm has "Buy" rating by Oppenheimer given on Tuesday, July 18. The firm earned "Buy" rating on Saturday, September 23 by RBC Capital Markets. Goldman Sachs Gp holds 0.01% of its portfolio in Brinker International, Inc. Therefore 74% are positive. MicroStrategy had 18 analyst reports since July 29, 2015 according to SRatingsIntel. Wood has "Hold" rating and $16 target. The stock now has a consensus rating of "Buy" and a consensus target price of $224.56. The company was maintained on Monday, October 16 by Northland Capital. Cetera Advisor Networks LLC now owns 19,034 shares of the healthcare conglomerate's stock worth $2,665,000 after buying an additional 7,170 shares during the period. The company was maintained on Thursday, September 21 by Citigroup. The firm has "Buy" rating by Cross Research given on Monday, February 22. The firm has "Neutral" rating by Mizuho given on Friday, July 29.

Healthcor Management Lp increased Bristol Myers Squibb Co (NYSE:BMY) stake by 365,120 shares to 815,120 valued at $45.42 million in 2017Q2. It also reduced Msci Eafe Etf (EFA) stake by 9,305 shares and now owns 8,950 shares.

Among 8 analysts covering INVESCO MORTGAGE CAPITAL INC (NYSE:IVR), 5 have Buy rating, 0 Sell and 3 Hold.

Investors sentiment decreased to 0.86 in 2017 Q2. Its up 0.02, from 1.19 in 2017Q1. 31 funds opened positions while 32 raised stakes. Ameriprise Financial has 81,268 shares. Ftb Advisors invested in 1,375 shares or 0.03% of the stock. The New York-based Berson & Corrado Investment Advisors Llc has invested 0.11% in the stock. Intl Ca has invested 0.24% in UnitedHealth Group Incorporated (NYSE:UNH). Following the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. 387,712 are owned by Lazard Asset Management Ltd Liability. Morgan Stanley has invested 0.01% in MicroStrategy Incorporated (NASDAQ:MSTR). Natl Asset Mgmt holds 9,284 shares or 0.31% of its portfolio. Ajo Lp accumulated 12,923 shares. Meeder Asset Management has invested 0% of its portfolio in MicroStrategy Incorporated (NASDAQ:MSTR).

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE